L350-2375 Screening compound: N-[7-ethoxy-2-(3-methoxyphenyl)imidazo[2,1-b][1,3]benzothiazol-3-yl]-N-(2-methoxyethyl)amine

L350-2375 Screening compound: N-[7-ethoxy-2-(3-methoxyphenyl)imidazo[2,1-b][1,3]benzothiazol-3-yl]-N-(2-methoxyethyl)amine
L350-2375 Screening compound: N-[7-ethoxy-2-(3-methoxyphenyl)imidazo[2,1-b][1,3]benzothiazol-3-yl]-N-(2-methoxyethyl)amine alternative view

Chemical Structure Depiction of ChemDiv screening compound L350-2375
N-[7-ethoxy-2-(3-methoxyphenyl)imidazo[2,1-b][1,3]benzothiazol-3-yl]-N-(2-methoxyethyl)amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L350-2375

Molecular Formula

C21H23N3O3S (C21 H23 N3 O3 S)

Compound Name

N-[7-ethoxy-2-(3-methoxyphenyl)imidazo[2,1-b][1,3]benzothiazol-3-yl]-N-(2-methoxyethyl)amine

IUPAC name

10-ethoxy-N-(2-methoxyethyl)-4-(3-methoxyphenyl)-7-thia-25-diazatricyclo[6.4.0.0^{26}]dodeca-1(8)35911-pentaen-3-amine

SMILES

CCOc(cc1)cc(s2)c1n1c2nc(-c2cc(OC)ccc2)c1NCCOC

InChI

InChI=1S/C21H23N3O3S/c1-4-27-16-8-9-17-18(13-16)28-21-23-19(14-6-5-7-15(12-14)26-3)20(24(17)21)22-10-11-25-2/h5-9,12-13,22H,4,10-11H2,1-3H3

InChI Key

NAJPWKXVFMREKJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27247744

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

397.5

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.994

Distribution Coefficient, logD

4.704

Water Solubility, LogSw

-4.63

Polar Surface Area

42.272

Acid Dissociation Constant (pKa)

22.60

Base Dissociation Constant (pKb)

7.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

L350-2375 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with L350-2375 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L350-2375?
Check Price and Availability of L350-2375, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L350-2375 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L350-2375
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L350-2375
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L350-2375 available by request